Philips said that claims related to its recall and post-recall conduct are preempted by the Federal Food, Drug, and Cosmetics Act which stops individuals from enforcing Food and Drug Administration regulations or seek recovery based on FDCA and FDA non-compliance, according to the company’s motion to dismiss filed Monday in the US District Court for the Western District of ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.